Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPH vs Lantus Regimen in Hospitalized Type 2 Diabetes
NCT02189395Phase 4Terminated
- Sponsor
- Riverside University Health System Medical Center
- Start
- Apr 2013
- Primary completion
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Riverside University Health System Medical Center. Started Apr 2013; status: terminated.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02189395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02189395.